高级检索
当前位置: 首页 > 详情页

Therapeutic potential of autophagy in immunity and inflammation: current and future perspectives

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]First Peoples Hosp Yunnan Prov, Dept Pharmacol, Kunming 650032, Yunnan, Peoples R China [2]Kunming Univ Sci & Technol, Affiliated Hosp, Dept Pharmaceut Sci, Kunming 650032, Yunnan, Peoples R China [3]First Peoples Hosp Yunnan Prov, Inst Clin & Basic Med Sci, Yunnan Prov Key Lab Clin Virol, Kunming 650032, Yunnan, Peoples R China
出处:
ISSN:

关键词: Autophagy Inflammation Disease Chemoprevention Cancer

摘要:
Autophagy is recognized as a lysosomal degradation pathway important for cellular and organismal homeostasis. Accumulating evidence has demonstrated that autophagy is a paradoxical mechanism that regulates homeostasis and prevents stress under physiological and pathological conditions. Nevertheless, how autophagy is implicated in immune responses remains unclear. It is well established that autophagy bridges innate and adaptive immunity, while autophagic dysfunction is closely related to infection, inflammation, neurodegeneration, and tumorigenesis. Therefore, autophagy has attracted great attention from fundamental and translational fields due to its crucial role in inflammation and immunity. Inflammation is involved in the development and progression of various human diseases, and as a result, autophagy might be a potential target to prevent and treat inflammatory diseases. Nevertheless, insufficient autophagy might cause cell death, perpetrate inflammation, and trigger hereditary unsteadiness. Hence, targeting autophagy is a promising disease prevention and treatment strategy. To accomplish this safely, we should thoroughly understand the basic aspects of how autophagy works. Herein, we systematically summarized the correlation between autophagy and inflammation and its implication for human diseases.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 3 区 医学
小类 | 3 区 药学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 药学
JCR分区:
出版当年[2022]版:
Q2 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q2 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]First Peoples Hosp Yunnan Prov, Dept Pharmacol, Kunming 650032, Yunnan, Peoples R China [2]Kunming Univ Sci & Technol, Affiliated Hosp, Dept Pharmaceut Sci, Kunming 650032, Yunnan, Peoples R China
通讯作者:
通讯机构: [1]First Peoples Hosp Yunnan Prov, Dept Pharmacol, Kunming 650032, Yunnan, Peoples R China [2]Kunming Univ Sci & Technol, Affiliated Hosp, Dept Pharmaceut Sci, Kunming 650032, Yunnan, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82490 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号